Clinical Ink Receives $4,300,000 Series B Round

  • Feed Type
  • Date
    10/18/2013
  • Company Name
    Clinical Ink
  • Mailing Address
    100 N Cherry St Winston-Salem, NC 27101 USA
  • Company Description
    Clinical Ink was launched in 2006 to provide eSource solutions for clinical research sites, eliminating the problems inherent to paper-based data collection and EDC alike. Rather than focusing on electronic case report forms, like EDC systems, Clinical Ink’s SureSource™ offers electronic source documents-providing the first true Electronic Source Record (ESR) in the clinical trials market.
  • Website
    http://www.clinicalink.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $4,300,000
  • Transaction Round
    Series B
  • Proceeds Purposes
    This infusion of funds will allow Clinical Ink to aggressively build the capabilities needed to address the rapidly increasing customer demand for eSource technology in clinical trials.
  • M&A Terms
  • Venture Investor
  • Venture Investor